Posted on:
11/17/2019
title
|
5th
Hepatitis C Technical Advisory Group (TAG) Meeting: Science Symposium
November 18, 2019
|
|
TIME
|
PRESENTATIONS
|
SPEAKERS
|
|
9:00-9:30
|
Welcome and Opening Remarks
·
Activities
of the Scientific Committee of the National Hepatitis C Elimination Program,
2016-2019
|
Dr. Amiran
Gamkrelidze, NCDC
Dr.
Francisco Averhoff, US CDC
|
|
|
Dr.
Tinatin Kuchuloria, TEPHINET
|
|
9:30-10:15
|
Immediate
and Long-term Clinical Outcomes of DAA Treatment
|
|
|
|
·
Assessment of the national hepatitis C elimination program: treatment
outcomes and associated factors, 2015-2019
|
Dr. Lali Sharvadze, IDACIRC
|
|
|
·
Challenges to HCV micro-elimination in HIV/HCV co-infection in Georgia
|
Dr. Nikoloz Chkhartishvili, IDACIRC
|
|
|
·
Long-term health outcome among HCV patients with advanced liver
fibrosis treated through the HCV elimination program
|
Dr. Maia Kajaia, Health Research Union (HRU)
|
|
10:15-11:15
|
Evaluation
of Diagnostics and Treatment Delivery Models Both at Specialized and Non-specialized
HCV Care Settings
|
|
|
|
·
Integrating HCV screening and simplified treatment services in primary
healthcare
|
Dr. Akaki Abutidze, IDACIRC
|
|
|
·
Effectiveness of three models of HCV diagnostics in
harm reduction: Impact on linkage to care—A pilot project in Georgia
|
Dr. Sonjelle Shilton, FIND
|
|
|
·
Integration of HCV RNA testing on existing GeneXperts in Georgia to
assist in current HCV care decentralization efforts
|
Dr. Maia Japaridze, FIND
|
|
11:15-11:45
|
BREAK
|
|
|
11:45-12:30
|
Novel Approaches to Laboratory Diagnostics
|
|
|
|
·
Evaluation
study of HCV Rapid Diagnostic Tests (RDTs), dry blood spots for HCV RNA testing, and the Genedrive® HCV ID Kit in Georgia
|
Dr. Maia
Alkhazashvili, NCDC
|
|
|
·
Evaluation
of the diagnostic performance of HCVcAg as test of cure in for hepatitis C
among PWID in Georgia
|
Dr.
Nazibrola Chitadze, NCDC
|
|
|
·
Using next generation sequencing (NGS) capacity for hepatitis C surveillance
in Georgia
|
Dr. Adam
Kotorashvili, NCDC
|
|
12:30-1:00
|
Surveillance
|
|
|
|
·
Establishing a Georgian PWID cohort study to estimate incidence of HCV
infection
|
Dr. Ketevan Shermadini IDACIRC
|
|
|
·
HCV reinfection in people living with HIV in Georgia
|
Dr. Pati Gabunia, IDACIRC
|
|
1:00-2:00
|
LUNCH
|
|
|
2:00-2:30
|
Surveillance
·
HCV-attributable hepatocellular carcinoma among persons with
hepatobiliary cancer diagnoses in Georgia: 2015-2016
·
Impact on mortality of HCV treatment with direct acting anti-viral
medications, Georgia, 2015-2018
|
Dr. Ana
Aslanikashvili, NCDC
Dr. Lia Gvinjilia, TEPHINET
|
|
2:30-2:45
|
Economic Evaluation
·
Estimation
of the cost effectiveness of the HCV treatment program in Georgia
|
Dr.
Josephine Walker, University
of Bristol
|
|
2:45-3:15
|
BREAK
|
|
|
3:15-4:00
|
Hepatitis B
·
Prevalence and risk factors for the hepatitis B infection – 2015
serosurvey results
·
Progress and challenges in HBV prevention, care and treatment
·
Epidemiology and treatment outcomes of HBV infection among HCV patients
treated with Direct Acting Antivirals (DAAs)
|
Dr. Ana Kasradze, NCDC
Dr. Mamuka Zakalashvili, Clinic
Mrcheveli
Dr. Maia Butsashvili, Health Research Union
|
|
4:00-4:45
|
Mother-to -Child
Transmission of Viral Hepatitis B and C
·
Overview of the maternal and child state program in Georgia
·
HCV Screening and linkage to care in antenatal clinics
·
Knowledge and perceived risk of HCV infection
among women of reproductive age in Georgia
|
Dr. Vladimer
Getia, NCDC
Dr.
Muazzam Nasrullah, US CDC
Dr.
Tinatin Abzianidze, Health Research Union
|
|
4:45-5:00
|
Final Remarks
|
Dr. Amiran
Gamkrelidze, NCDC
|
|
5th Hepatitis
C Technical Advisory Group (TAG) Meeting: Day 1
November 19, 2019
|
|
8:30-9:00
|
Registration
|
|
|
9:00-9:30
|
Welcome and Opening Remarks
|
Ekaterine
Tikaradze, Minister
of Internally Displaced Persons from the Occupied Territories, Labour, Health
and Social Affairs of Georgia
Ms. Elizabeth
Rood, Chargé
d’Affaires, US Embassy
Dr. Carolyn
Wester, US CDC
Dr. Betty Chiang, Gilead Sciences
Dr. Silviu
Domente, WHO Georgia
Office Head
|
|
9:30-10:00
|
Introduction of TAG Members and Role of the TAG
·
Purpose of the meeting and overview of agenda
·
Introduction of TAG members
·
Review 2018 TAG recommendations
|
Dr. Carolyn Wester, US CDC (Chair) & Dr.
Margaret Hellard, Burnet Institute, Australia (Co-Chair)
|
|
10:00-10:30
|
Progress
and Challenges of the HCV Elimination Program in Georgia 2015-2019
|
Dr. Tamar Gabunia,
Ministry of Internally
Displaced Persons from the Occupied Territories, Labour, Health and Social
Affairs of Georgia (MOH)
|
|
10:30-11:00
|
Media Coverage/Break
|
|
|
11:00-11:15
|
The interim impact and ongoing treatment requirements for
achieving HCV elimination in Georgia
|
Dr. Peter Vickerman,
Bristol University, UK
|
|
11:15-11:45
|
Key
issues and challenges for achieving HCV elimination in Georgia
|
Dr. Francisco Averhoff, US
CDC
|
|
11:45-1:30
11:45-12:15
12:15-1:30
|
Identify
Persons Infected with HCV (and Linked to Care)
·
TAG 2018 recommendations, status of HCV screening:
successes, challenges, and plans to address challenges
Discussion by TAG/Q & A
|
TAG moderators: Dr. Carlos Del Rio, Emory University, USA & Dr. Sharon
Hutchinson, National Health Service, Scotland, UK
Discussants: Irma
Khonelidze, NCDC, Alexander Turdziladze, NCDC, Vladimer Getia, NCDC, Muazzam
Nasrullah, US CDC
Dr. Amiran Gamkrelidze, NCDC
|
|
1:30-2:30
|
Lunch
|
|
|
2:30-3:30
2:30-2:50
2:50-3:00
3:00-3.30
|
Provide HCV Care and Treatment
·
TAG 2018 recommendations, status of HCV care and
treatment: successes, challenges, and plans to address challenges including
simplified testing and cure strategies in decentralization of HCV services
·
Update on HCV screening, care and treatment in Georgia’s
Corrections System
Discussion by TAG/Q & A
|
TAG moderators: Dr. Graham Foster, University of London,
UK & Dr. Jorge Mera, Cherokee Nation, US
Discussants: Tengiz Tsertvadze, IDACIRC, Eka Adamia, MOH, Lali
Sharvadze, IDACIRC, Akaki Abutidze, IDACIRC, Uka Kiladze, National Family Medicine
Center, Maia Butsashvili, HRU, Jaba Zarkua, Clinic Mrcheveli, Maka Gogia,
GHRN
Dr. Tengiz Tsertsvadze, IDACIRC
Ministry
of Justice of Georgia, Special Penitentiary Service
|
|
3.30-3:50
|
BREAK
|
|
|
3:50-4:50
3:50-4:05
4:05-4:50
|
Promote Advocacy, Awareness, Education, and
Partnerships for HCV-Associated Resource Mobilization
·
TAG 2018 recommendations, status of
education/advocacy efforts: successes, challenges, and plans to address
challenges
Round
Table/Discussion by TAG/Q & A
·
Temur
Radiani,
Hepatitis C Cured Patient Association
·
Maia Butsashvili, Health Research Union (HRU)
·
Konstantine
Rukhadze, Georgia Community Advisory
Board (GeCAB)
·
Maka
Gogia, Georgia Harm Reduction Network
·
Konstantine
Labartkava, New Vector
|
TAG moderators: Dr. Tatjana
Reic, European Liver Patients Association,
Croatia & Dr. Jeff Lazarus,
EASL International Liver Foundation, Switzerland
Discussants: Temur Radiani, Patient Association, Maia
Butsashvili, HRU, Konstantine Rukhadze, GeCAB
Dr. Marina Topuridze, NCDC
|
|
4:50-5:50
4:50-5:15
5:15-5:50
|
Activities to Improve HCV Surveillance and Program
Effectiveness
·
TAG 2018 recommendations, status of HCV
surveillance: successes, challenges,
and plans to address challenges
Discussion by TAG/Q & A
|
TAG moderators: Dr. Antons Mozalevskis,
WHO-EURO, Denmark & Dr. Priti
Patel, US CDC
Discussants: Khatuna Zakhashvili, NCDC,
Maia Butsashvili, HRU, Tinatin Kuchuloria, TEPHINET, Lia Gvinjilia, TEPHINET,
Tsira Merabishvili, NCDC, Ketevan Galdavadze, NCDC, Maia Japaridze, FIND
Maia Tsereteli, NCDC
|
|
5:50-6:00
|
Summary
of Day 1 and Closing Remarks
|
Dr.
Carolyn Wester, US CDC
|
|
6:30
|
Reception/Dinner
at Republic hosted by FIND
|
|
|
5th Hepatitis
C Technical Advisory Group (TAG) Meeting: Day 2
November
20, 2019
|
|
TIME
|
PRESENTATIONS
|
SPEAKERS
|
|
9:00-9:15
|
Opening Remarks, Review Day 1
|
Dr. Carolyn Wester, US CDC (Chair) & Dr.
Margaret Hellard, Burnet Institute, Australia (Co-Chair)
|
|
9:15-10:15
9:15-9:45
9:45-10:15
|
Prevent HCV Transmission
i.
Harm
Reduction
·
TAG 2018 recommendations, update on prevention,
screening and linkage to treatment of PWID
·
Decentralization of HCV screening, care, and
treatment in harm reduction settings
Discussion by TAG/Q & A
|
TAG moderators: Dr. Margaret Hellard, Burnet
Institute, Australia, Dr. Sharon Hutchinson, National Health Service, Scotland,
UK
Discussants: Irma
Khonelidze, NCDC, Maka Gogia, GHRN, Konstantine Rukhadze, GeCAB
Dr. Ketevan Stvilia, NCDC
Dr. Maia Butsashvili, Health Research Union
|
|
10:15-10:35
|
BREAK
|
|
|
10:35-11:15
10:35-11:05
11:05-11:15
|
Prevent HCV Transmission (continued)
ii.
Blood
Safety
·
TAG 2018 recommendations, status of blood safety
program in blood banks: successes, challenges, and plans to address
challenges
·
Blood Bank screening quality assurance: Current
practices and future directions
Discussion by TAG/Q & A
|
TAG moderators: Dr. Evan Bloch, Johns Hopkins
University, US & Dr. Anders
Widell, Lund University, Sweden
Discussants: Khatuna Zakhashvili, NCDC,
Vladimer Getia, NCDC, Maia Alkhazashvili, NCDC, Keti Shermanidi, IDACIRC, Marina Baidauri, MOH, Radu
Cojocaru, CDC
Dr. Maia Alkhazashvili, NCDC
Dr. Nazibriola Chitadze, NCDC
|
|
11:15-11:45
11:15-11:25
11:25-11:45
|
Prevent HCV Transmission (continued)
iii.
Infection
Control in Healthcare, Non-traditional Healthcare and Other Community
Settings
·
TAG 2018 recommendations, status of infection
prevention and control: successes, challenges, and plans to address
challenges
Discussion by TAG/Q & A
|
TAG moderators: Dr. Priti Patel, US CDC & Dr. Antons Mozalevskis, WHO-EURO,
Denmark
Discussants: David
Tsereteli, NCDC, Giorgi Chakhunashvili, NCDC, Marina Baidauri,
Dr. Marine Baidauri, Ministry of Internally
Displaced Persons from the Occupied Territories, Labour, Health and Social
Affairs of Georgia (MOH)
|
|
11:45-12:20
11:45-12:00
12:00-12:20
|
Improve HCV Laboratory Diagnostics
TAG 2018 recommendations, status of laboratory and diagnostics
efforts: successes, challenges, and plans to address challenges including
role of diagnostics in decentralization of HCV services
Discussion by TAG/Q & A
|
TAG moderators: Dr. Anders Widell, Lund
University, Sweden & Dr. Evan
Bloch, Johns Hopkins University, US
Discussants: Nazibriola
Chitadze, NCDC, Vladimer Getia, NCDC, Irma Khonelidze, NCDC, Maia Japaridze,
FIND, George Kamkamidze, Neolab, Lana Gatserelia, IDACIRC
Dr. Maia
Alkhazashvili, NCDC
|
|
12:20-1:20
12:20-1:00
1:00-1:20
|
Lessons Learned from Other Countries
Presentations
·
Australia
·
Scotland, UK
·
Cherokee Nation
Round Table Discussion
|
TAG moderators: Dr. Carolyn Wester, US CDC & Dr.
Carlos Del Rio, Emory University, USA
Dr.
Margaret Hellard, Burnet Institute, Australia
Dr. Sharon Hutchinson, National Health Service, Scotland, UK
Dr. Jorge Mera, Cherokee Nation, USA
|
|
1:20-4:20
|
Lunch for All and Free Time
TAG Members Lunch
|
|
|
4:20-5:50
|
TAG Recommendations and 2019 Priorities
|
Dr. Carolyn Wester, US CDC & Dr.
Margaret Hellard, Burnet Institute, Australia & TAG members
|
|
5:50-6:00
|
Closing Remarks
|
Dr. Carolyn Wester, US CDC
|